Linc AB (6ZB) Stock Price & Analysis
6ZB Stock Chart & Stats
- Day’s Range
- EUR 6.29 - EUR 6.29
- 52-Week Range
- EUR 5.52 - EUR 7.01
- Previous Close
- EUR 6.16
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 372.36M
- Enterprise Value
- EUR 3.91B
- Total Cash (Recent Filing)
- EUR 65.59M
- Total Debt (Recent Filing)
- EUR 0
- Price to Earnings (P/E)
- 56.6
- Beta
- 0.46
- Next Earnings
- Jan 21, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
A debt-free structure materially reduces refinancing and interest-burden risk, preserving flexibility through earnings volatility. It also gives Linc greater capacity to support portfolio companies, pursue investments, and absorb periods of weaker cash generation without relying on external leverage.
Focused Nordic Life Science Investment Model
A focused investment mandate can build durable sector expertise and improve the consistency of portfolio selection and support. Exposure across several life science subsectors also broadens the opportunity set while retaining a clear regional and strategic specialization.
Active Portfolio-company Support
Long-term ownership and active board involvement provide a hands-on value-creation model rather than purely passive holdings. Strategic and operational support can strengthen portfolio-company development over multiple years and help Linc influence outcomes across its investments.
Bears Say
Highly Volatile Earnings
Large swings between losses and profits make reported earnings difficult to treat as a stable measure of underlying performance. The volatility can complicate planning, reduce confidence in recurring earnings power, and make future shareholder returns more dependent on investment outcomes.
Unstable Cash Generation
Repeated negative operating and free cash flow indicate that accounting profitability has not consistently translated into cash generation. This raises execution risk and may limit the company’s ability to fund portfolio support or new investments internally despite its strong balance sheet.
Weak Underlying Operating Revenue
Small, inconsistent revenue and negative TTM gross profit point to limited visibility into the company’s underlying operating economics. The revenue decline further weakens evidence of a steadily expanding core business and increases reliance on investment or valuation-related income.
6ZB FAQ
What was Linc AB’s price range in the past 12 months?
What is Linc AB’s market cap?
When is Linc AB’s upcoming earnings report date?
How were Linc AB’s earnings last quarter?
Is Linc AB overvalued?
Does Linc AB pay dividends?
What is Linc AB’s EPS estimate?
How many shares outstanding does Linc AB have?
What happened to Linc AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Linc AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Linc AB
Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
- Sector
- Financial
- Industry
- Asset Management
- CEO
- Karl Tobieson
- Employees
- 2
- Website
- linc.se
- Address
- Vasagatan 28, Stockholm, AB, 111 20, SE
Linc AB (6ZB) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 3 | 6 |
| Technical Analysis | 2 | 3 | 4 |
| Moving Averages | 10 | 0 | 2 |